The potential benefit of endovascular aneurysm repair (EVAR) in the setting of aortic rupture is debated. Retrospective studies have shown lower mortality after EVAR for rupture when compared with open repair but these findings have not been replicated in randomized trials. In the current report, the outcome of ruptured AAA repair was analyzed in a national registry based on the primary strategy for treatment at center level. The results support the early findings of the randomized trials. The peri-operative and midterm mortality after ruptured AAA is equal in a modern real world clinical setting, irrespective of the primary operative strategy.
INTRODUCTION
Despite advances in medical care over the last few decades, ruptured abdominal aortic aneurysm (rAAA) remains a major threat to a patient's life, with a 90% overall and 30e 50% in hospital mortality. 1e4 The introduction of endovascular aneurysm repair (EVAR) in the treatment of AAA has resulted in reduced peri-operative mortality in the elective setting, 5, 6 with widespread use of this technique over the last decade for intact AAA repair. 7, 8 Although EVAR is increasingly used for the treatment of rAAA, uptake has been slower than in the elective setting, and the evidence for EVAR in treatment of ruptures remains scarce. 9e12 In an international database on vascular surgical procedures in nine countries, 12% of rAAAs were treated with EVAR. 7 Theoretically, there are potential benefits with EVAR of rAAA. Patients can often be treated under local anesthesia. General anesthesia in a bleeding patient is often associated with deep hypotension, and laparotomy can be avoided. In patients with obstructive lung disease, the risk of pulmonary complications is reduced, and the minimally invasive technique can potentially allow treatment of elderly comorbid patients who are otherwise not considered for open surgical rAAA repair. However, a primary EVAR strategy for rAAA could result in delayed control of aortic hemorrhage, owing to the need for a computed tomography scan and case planning prior to treatment. In addition, while vascular centers traditionally have routines for urgent open aortic cross clamping to stabilize patients in shock, endovascular know how and operating facilities are often not available 24/7.
Although several reports indicate excellent short-term outcome after EVAR for rAAA, the claimed superiority of this treatment strategy compared with open repair is debated. 13, 14 The superior outcome of EVAR for rAAA seen in observational studies may be an effect of case selection, making comparison with open repair inadequate. 7, 12 Three randomized trials on open and endovascular treatment of rAAA have been published. 9, 10, 15 The results reported to date do not indicate any difference in peri-operative mortality, and long-term outcome data are not available. Although the randomized controlled trials form an excellent basis for comparison of these two operative techniques for the treatment or rAAA, the randomized setting also includes a selection bias, which may affect the generalizability. Owing to the uncertainty regarding best treatment, the primary strategy for treatment of rAAA varies significantly between centers. In Sweden, the rate of EVAR treatment of ruptures varies from 0 to 100% between centers.
Registries with high validity contribute to evidence based medicine through an opportunity to test the findings of randomized trials in a real world setting. 16 The current report aims to assess the effect of primary treatment strategy for rAAA on outcome in a contemporary population-based national registry. The study focuses primarily on treatment strategy, rather than treatment modality, with the hypothesis that centers with a primary EVAR strategy would achieve different peri-operative mortality after rAAA, and would treat older and more comorbid patients with rupture.
METHODS
The Swedvasc registry, a nationwide prospective vascular surgical registry in Sweden, validated internally and externally with > 90% coverage for AAA repair and 100% accurate mortality data explained by automatic cross-linkage with the population registry 17 was investigated. All ruptured AAA repairs performed in Sweden on Swedish citizens > 50 years of age registered during the period May 2008e December 2012 were identified. Operations performed at centers with no elective aortic surgery were excluded from the analysis. Patient characteristics, including age and preoperative comorbidities, were assessed.
To assess the effect of operative strategy for rAAA on outcome, centers were divided into two groups. Hospitals performing EVAR in > 50% of rAAA cases were classified as primary EVAR strategy centers (pEVARc) versus those with a < 50% rate of EVAR classified as primary open repair strategy centers (pORc). Patient characteristics were compared between groups, including the following comorbidities: cardiac disease (history of ischemic heart disease, congestive heart failure or cardiac intervention/operation), respiratory disease (any diagnosed pulmonary disease), diabetes (diet, tablet, or insulin treated diabetes mellitus), cerebrovascular disease (history of transient ischemic attack or stroke) and renal disease (pre-operative creatinine level [mmol/L]). Thirty day, 1 year, and 2 year survival, as well as peri-operative complications, were analyzed. Data were analyzed including and excluding referrals, an important analysis as pEVARc were all referral centers. Referred patients were identified based on comparison of the local residence address of the patient and operating center for rAAA, based on zip code. A patient with a local vascular centre in his/her residential area, but operated on at a referral center covering the area, was defined as a referral. Patients that were operated on at a referral center not covering their zip code area were not defined as referrals, as the patient is then more likely to have ruptured at a location away from their residence. No patients were operated on at a county hospital outside their residential zip code area. Subgroup analyses were performed, assessing patient characteristics and outcome, based on age and center level (referral centers vs. county hospitals) and pre-operative status. Uni-and multivariate analyses of predictors of peri-operative mortality were performed.
There were no data available on the treatment turndown rate for rAAA at different centers. To analyze variations in the rate of treated rAAA, the incidence of rAAA surgery per 100,000 inhabitants > 50 years of age were assessed in primary EVAR versus primary open repair centers for the period 2009e12. Regional population data were retrieved from Statistics Sweden. 18 The rate of rAAA repair was calculated based on number of registered rAAA repairs in Swedvasc as proportion of population.
Statistics
Independent samples t test was used for comparison of normally distributed data. Missing values were handled by case deletion. Rates were compared with the chi-square test. For analysis of mortality, 30 day outcome was assessed with the chi-square test, and midterm mortality was estimated with KaplaneMeier analysis and differences were tested with the log-rank test. Uni-and multivariate binary logistic regression with forced entry was used to estimate the odds ratios for predictors of peri-operative mortality. A two-tailed p-value of < .05 was considered significant. Statistical analyses were performed with IBM SPSS Statistics software version 22.0 (IBM, Armonk, NY, USA).
Ethical approval for the project was obtained from the Regional Ethical Board of Uppsala (Dnr 2014/078).
RESULTS
Over the study period, 1,324 operations for infrarenal aortic rupture were registered in the Swedvasc registry. Twenty (1.5%) rupture repairs performed at centers not performing elective aortic surgery were excluded from this analysis. Three referral centers performed EVAR in > 50% (range 58.3e87.7%) of all ruptures over the study period and were defined as pEVARc ( Fig. 1; Table 1 ). These centers treated a total of 236 patients, of whom 74.6% underwent EVAR. At the remaining 26 centers defined as pORc, 1,068 patients were operated on, of whom 15.6% underwent EVAR (range 0e38.5%). Patient characteristics are presented in Table 2 . Patients treated at pEVARc were more often referrals, had a higher rate of respiratory comorbidity, and higher registered pre-operative systolic blood pressure. The pEVARc had a higher rate of patients with pre-operative loss of consciousness among those treated with EVAR (41.9%) than the pORc (27.1%; p ¼ .01), while there was no difference in the rate of pre-operative loss of consciousness in patients treated with open repair (pEVARc 48.1%, pORc 51.8%; p ¼ .67). There was no difference in mortality after repair between pEVARc and pORc (p ¼ .07) ( Table 3 ; Fig. 2A ). Mortality was lower for patients treated with EVAR compared with open repair, both at pEVARc and pORc.
Patients treated with open repair at pEVARc had a higher 1 and 2 year mortality rate than those undergoing open repair at pORc (Table 3) .
Data were scrutinized to assess the effect on outcome of the higher rate of referrals at the primary EVAR centers. The referred patients were younger (73.3 years vs. 74.8 years; p ¼ .05) and had a higher pre-operative systolic blood pressure (85.2 mmHg vs. 73.2 mmHg; p ¼ .01) than the non-referred patients. There was no difference in mortality between referred and non-referred patients. An exclusion of the referred cases from the analysis of mortality outcome at the pEVARc and pORc did not affect the mortality up to 2 years (Table 3) , but there was a higher mortality rate over time in the pEVARc group (p ¼ .03) (Fig. 2B) . Subgroup analyses were performed for octogenarians, showing no difference in mortality (Table 3) .
To assess the effect of other potential confounders, perioperative outcome was compared for referral centers and county hospitals. Thirty day mortality was equal in both However, owing to the lower EVAR mortality, the overall mortality for rupture did not differ between these groups.
Peri-operative complications are presented in Table 4 . There was a higher proportion of patients with massive peri-operative bleeding at the pORc, while endoleakage and need for laparotomy for abdominal compartment syndrome were more common at pEVARc. A univariate analysis of predictive factors for peri-operative mortality after rAAA pointed out age, cardiac disease, renal impairment, and preoperative loss of consciousness as predictors. In the multivariate analysis, age, renal impairment, and pre-operative loss of consciousness remained significant predictors of mortality ( Table 5 ).
The incidence of rAAA repair per 100,000 inhabitants > 50 years of age was assessed in the primary uptake area of pEVARc and pORc, respectively, for the period 2009e12. Referred patients were allocated to their primary uptake area in order to avoid distortion of the rate of repair at referral centers. The incidence of rAAA repair was lower in pEVARc regions (6.07, 95% confidence interval [CI] 5.01e 7.13) when compared with pORc regions (8.15, 95% CI 7.64e8.66). No correction could be performed for the prevalence of disease.
DISCUSSION
In this population based study the treatment of rAAA based on primary operative strategy in a nationwide vascular surgical registry with excellent validity was analyzed. A quarter of all rAAA repairs in Sweden were performed with an endovascular technique in the study period, with significant variation in the rate of EVAR between centers. From an international perspective, this is on the same level as the rate of EVAR treatments performed for rAAA in the USA, and more than twice the rate of EVAR for ruptures in the UK. 19 The distinct difference in operative strategy between centers, with selected centers preferring EVAR when possible and others adhering to open repair as the primary strategy, offered an opportunity to assess the overall outcome of rAAA repair based on primary treatment strategy in this national cohort. The benefits of population based studies include the non-selective patient cohort, which reflects contemporary real world practice and outcome. It has been argued, for instance, that the proportion of general anesthesia in the EVAR arm of the IMPROVE trial was unexpectedly high, which may have affected the peri-operative mortality negatively. 10, 12, 20, 21 The prospective data collection in this national registry with predefined variables may, however, limit the comparability of this report to previous trials in certain aspects (e.g., length of stay and discharge status).
The current study confirms that there is no early or midterm survival difference between primary open and endovascular operative strategies for rAAA. No difference could be found when referrals were excluded from the analysis. The results of the current study harmonize with the findings of the previously published randomized trials. 9, 10, 15 The IMPROVE trial, which had a similar set up to this study in assessing the role of primary treatment strategy on outcome rather than the role of operative technique, found a mortality rate of 36.4% in the endovascular strategy group versus 40.1% in the open repair group. 10 Overall, the peri-operative mortality rate in the current Swedish cohort was lower than in the IMPROVE trial, and in agreement with the Amsterdam trial.
9,10 National differences in outcome of AAA repair have previously been reported and may explain this variation. 7 Peri-operative mortality was lower for patients selected for EVAR when compared with open repair in the overall cohort. This is in line with previous population and center based reports. 7, 13, 19, 21 However, this result is affected by case selection at both pEVARc and pORc, as patients are selected for treatment with open repair or EVAR based on aortic anatomy and hemodynamic stability. Indeed, the equal survival outcome based on primary treatment strategy at center level supports that fact that the improved peri-operative outcome after EVAR seen in retrospective studies is likely to be due to selection bias.
The current report indicates that pEVARc treat more patients with respiratory comorbidity and with less peri- operative bleeding. However, these benefits of the less invasive treatment strategy did not translate into lower peri-operative mortality, neither overall, nor in subgroup analyses. The pEVARc had a higher peri-operative mortality at 1 and 2 years after open repair than pORc. It is reasonable to believe that the patients selected for open repair at centers with a primary EVAR strategy had a challenging anatomy for endovascular treatment. A challenging aortic neck anatomy is, per se, associated with a higher risk of peri-operative mortality. 22 Nonetheless, the minimally invasive treatment strategy could be of importance to the patient. Although data on mode of anesthesia were not available in the registry, > 90% of EVAR patients were treated by percutaneous access, indicating a primary local anesthetic approach in these cases. Laparotomy for abdominal compartment syndrome (ACS) was performed in 9.5% of patients treated at pEVARc, and was more frequent than at pORc. ACS is a dreaded complication, associated with a high mortality rate, and is encountered after both open and endovascular rAAA repair. 23, 24 The difference in frequency of re-laparotomy for ACS may have been affected by local routines, where some centers preferred to leave the abdomen open in the early post-operative period after surgical rAAA repair in order to avoid ACS development.
As the primary EVAR centers in the current study were all referral centers, a higher rate of referrals were treated in the pEVARc group. The results were assessed to correct for this important difference in case selection. Although it was anticipated that the referral patients would be more complex with a potentially poorer outcome, no indication of this could be found in the analyses. On the contrary, data indicate that referrals are more stable pre-operatively, which is a predictor of better outcome for rAAA repair. 9 Exclusion of the referrals from the analyses did not change the patient characteristics nor the mortality rate. The KaplaneMeier curve indicates a higher midterm mortality at the pEVARc, which may reflect the increased preoperative morbidity rate among patients treated at these centers. The pEVARc were all teaching hospitals with a relatively high volume of patients. The better outcome associated with high surgical volume could have been expected to affect the outcome in the pEVARc in the positive direction. Despite this, there was no difference in outcome between the two groups. It is possible that a minimally invasive primary strategy for treatment of rAAA would result in a higher rate of active intervention in patients with rupture. In a recent report, Karthikesalingam et al. reported a higher overall survival rate for rAAA in the USA compared with England, owing to a higher rate of active treatment in the USA. 19 This difference in active surgical treatment was partly due to the higher rate of EVAR for ruptures in the US setting. In the current report, the incidence of rAAA repair was surprisingly lower in the regions with pEVARc when compared with pORc. Although this crude measure does not correct for potential variations in prevalence of disease, the finding at least does not indicate a more liberal approach to rAAA treatment in the pEVARc in Sweden.
CONCLUSION
In this population based study, there was no difference in mortality outcome after rAAA repair among centers with a primary EVAR approach when compared with a primary OR strategy. Although patients treated with EVAR had lower short-term mortality compared with those undergoing open repair, this is likely to be an effect of case selection and did not result in an overall difference in rAAA mortality based on primary treatment strategy of centers. The study supports the findings of the previously performed randomized controlled trials in a national registry with confirmed high validity.
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